← Back to Search

Other

Moringa Powder Acceptability in Healthy Adults

N/A
Waitlist Available
Led By Susana Matias, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults aged 18-65
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial tests if taking Moringa powder can help improve people's health.

Who is the study for?
This trial is for UC Berkeley staff aged 18-65 who can communicate in English or Spanish. It's designed to see how they feel about taking different amounts of Moringa powder every day.Check my eligibility
What is being tested?
The study tests the acceptability of three doses of Moringa powder taken daily by healthy adults. Participants are randomly assigned to one of the dose groups: low, medium, or high.See study design
What are the potential side effects?
Potential side effects from consuming Moringa powder may include digestive discomfort, allergic reactions, or changes in appetite but will vary based on individual tolerance and dose.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Consumption
Side effects
Secondary outcome measures
Daily dose consumed
Other outcome measures
Change in skin carotenoids
Taste
Texture
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Moringa Powder - Medium DoseExperimental Treatment1 Intervention
Group A
Group II: Moringa Powder - Low DoseExperimental Treatment1 Intervention
Group C
Group III: Moringa Powder - High DoseExperimental Treatment1 Intervention
Group B

Find a Location

Who is running the clinical trial?

University of California, BerkeleyLead Sponsor
176 Previous Clinical Trials
720,857 Total Patients Enrolled
University of California, DavisOTHER
908 Previous Clinical Trials
4,704,063 Total Patients Enrolled
1 Trials studying Tuberculosis
500 Patients Enrolled for Tuberculosis
Susana Matias, PhDPrincipal InvestigatorUniversity of California, Berkeley

Media Library

Moringa Powder (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05861076 — N/A
Tuberculosis Research Study Groups: Moringa Powder - Low Dose, Moringa Powder - Medium Dose, Moringa Powder - High Dose
Tuberculosis Clinical Trial 2023: Moringa Powder Highlights & Side Effects. Trial Name: NCT05861076 — N/A
Moringa Powder (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05861076 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment still accept participants?

"According to the clinicialtrials.gov website, this research project is recruiting patients at present. The trial was first published on March 1st 2023 and its most recent update occurred on May 5th of that same year."

Answered by AI

What is the aggregate participant count for this clinical experiment?

"Affirmative. The details listed on clinicaltrials.gov affirm that this experiment is actively enrolling participants; the trial was initially advertised on March 1st 2023 and has been modified most recently on May 5th of the same year. To complete the project, 60 volunteers are required at a single site."

Answered by AI

Are geriatric individuals being included as subjects in this trial?

"Patients of ages between 18 and 65 are being invited to partake in this study."

Answered by AI

Who is qualified to participate in this clinical trial?

"Those who wish to partake in this clinical trial must suffer from tuberculosis, be aged between 18 and 65, with a total of 60 participants being recruited."

Answered by AI
~24 spots leftby Mar 2025